Evidence map›Paper›PMID 39711880›Full record

ArticleFrontiers in pediatrics2024

Prevalence of

Estefânia Rodrigues Biojone, Bruna Cândido Guido, Larissa Lemos Mendanha Cavalcante, Agenor de Castro Moreira Dos Santos Júnior, Robéria Mendonça de Pontes, Felipe Magalhães Furtado, José Carlos Córdoba, Isis Maria Quezado Magalhães, Diêgo Madureira de Oliveira, Ricardo Camargo

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Estefânia Rodrigues BiojoneOncology and Hematology Division, Children's Hospital of Brasília, Brasília, Brazil.
Bruna Cândido GuidoLaboratory of Translational Research, Children's Hospital of Brasília, Brasília, Brazil.
Larissa Lemos Mendanha CavalcanteLaboratory of Translational Research, Children's Hospital of Brasília, Brasília, Brazil.
Agenor de Castro Moreira Dos Santos JúniorLaboratory of Translational Research, Children's Hospital of Brasília, Brasília, Brazil.
Robéria Mendonça de PontesLaboratory of Translational Research, Children's Hospital of Brasília, Brasília, Brazil.
Felipe Magalhães FurtadoOncology and Hematology Division, Children's Hospital of Brasília, Brasília, Brazil.
José Carlos CórdobaOncology and Hematology Division, Children's Hospital of Brasília, Brasília, Brazil.
Isis Maria Quezado MagalhãesOncology and Hematology Division, Children's Hospital of Brasília, Brasília, Brazil.
Diêgo Madureira de OliveiraMultidisciplinary Health Laboratory, Faculty of Health Sciences and Technology, University of Brasília, Brasília, Brazil.
Ricardo CamargoLaboratory of Translational Research, Children's Hospital of Brasília, Brasília, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: There is consistent evidence that Methods: We evaluated 156 children with B-ALL treated between July 2018 and September 2023. Screening for FLT3 mutations was performed using RFLP and fragment analysis, while FLT3 expression was assessed by qPCR. Results: Discussion: Our findings do not support the inclusion of

Indexed as

child healthmolecular biologyprecision medicineprecursor B-cell lymphoblastic leukemia-lymphomatumor biomarkers

Identifiers

PMID39711880
PMCPMC11658997

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.